Partners

Saniona’s drug research is conducted primarily in three ways:

 

 

● Through its own drug discovery and development at an early stage.

 

Through cooperation with major pharmaceutical companies

 

Through Joint Ventures.

 

From the collaborations Saniona may receive payments in the form of research payments, milestone payments and royalties on marketed products.

 

Saniona has ongoing collaboration agreements with:

 

 

Ataxion Inc.

 

Boehringer Ingelheim GmbH

 

Productos Medix, S.A de S.V

 

● The Michael J. Fox Foundation for Parkinson’s Research

 

 The Treatment Research Center (TRC), University of Pennsylvania

 

● Upsher-Smith Laboratories, Inc.